![Han-Gu Lee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Han-Gu Lee
Chief Executive Officer at RedoxBio Co., Ltd.
Net worth: 4 M $ as of 30/05/2024
Han-Gu Lee active positions
Companies | Position | Start | End |
---|---|---|---|
RedoxBio Co., Ltd.
![]() RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology RedoxBio Co., Ltd. engages in the manufacture and sale of materials for pharmaceutical products. It operates through Hyaluronic Acid and Chemical business divisions. Its products include hyaluronic filler, methylol cephalexin lysinate, sodium hyaluronate, and others. The company was founded on August 26, 2010 and is headquartered in Hwaseong-si, South Korea. | Chairman | - | - |
Chief Executive Officer | - | - | |
Director/Board Member | - | - |
Career history of Han-Gu Lee
Former positions of Han-Gu Lee
Companies | Position | Start | End |
---|---|---|---|
HLB PHARMACEUTICAL CO., LTD. | Director/Board Member | 27/03/2016 | 30/05/2017 |
Chief Executive Officer | 27/03/2016 | 30/05/2017 | |
DAE HWA PHARMACEUTICAL CO., LTD. | Chief Executive Officer | - | 19/03/2015 |
Chairman | - | 19/03/2015 |
Training of Han-Gu Lee
Sungkyunkwan University | Doctorate Degree |
Statistics
International
South Korea | 5 |
Operational
Chief Executive Officer | 3 |
Chairman | 2 |
Director/Board Member | 2 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
DAE HWA PHARMACEUTICAL CO., LTD. | Health Technology |
HLB PHARMACEUTICAL CO., LTD. | Health Technology |
![]() | Health Technology |
- Stock Market
- Insiders
- Han-Gu Lee
- Experience